Medpace Holdings, Inc.

MEDP

$416.04

Name : Medpace Holdings, Inc.

Sector : Healthcare

Industry: Diagnostics & Research

Mark. Cap: $11,807,750,144.00

EPSttm : 15.26

Medpace Holdings, Inc.

$416.04

1.86%

$7.89

Float Short %

5.87

Margin Of Safety %

Put/Call OI Ratio

1.04

EPS Next Q Diff

-0.71

EPS Last/This Y

1.1

EPS This/Next Y

1.8

Price

416.23

Target Price

505.18

Analyst Recom

3.4

Performance Q

-30.98

Relative Volume

2.46

Beta

1.43

Ticker: MEDP

21 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-01-14	MEDP	616.52	1.62	1.83	1507
2026-01-15	MEDP	617.64	1.60	0.32	1507
2026-01-16	MEDP	610.88	1.65	0.31	1506
2026-01-20	MEDP	602.52	1.71	9.00	1379
2026-01-21	MEDP	621.1	1.74	1.36	1399
2026-01-22	MEDP	606.1	1.72	8.17	1414
2026-01-23	MEDP	587.89	1.74	9.33	1425
2026-01-26	MEDP	602.5	1.81	2.80	1469
2026-01-27	MEDP	602.66	1.83	3.00	1484
2026-01-28	MEDP	597.95	1.83	2.33	1487
2026-01-29	MEDP	593.16	1.83	0.00	1488
2026-01-30	MEDP	582.42	1.82	999.99	1492
2026-02-02	MEDP	587.89	1.83	9.00	1498
2026-02-03	MEDP	568.63	1.85	17.33	1507
2026-02-04	MEDP	561.67	1.87	0.41	1525
2026-02-05	MEDP	542.01	1.77	1.57	1554
2026-02-06	MEDP	541.79	1.77	1.80	1555
2026-02-09	MEDP	530.94	1.77	3.09	1570
2026-02-10	MEDP	446.35	1.90	1.01	2330
2026-02-11	MEDP	423.14	1.39	0.44	3360
2026-02-12	MEDP	416.68	1.04	1.37	3601
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

21 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-01-14	MEDP	616.72	14.2	73.3	15.12
2026-01-15	MEDP	617.92	14.2	66.9	15.12
2026-01-16	MEDP	610.79	14.2	58.7	15.12
2026-01-20	MEDP	602.19	14.2	57.2	15.12
2026-01-21	MEDP	621.23	14.2	83.8	15.12
2026-01-22	MEDP	606.09	14.2	51.9	15.12
2026-01-23	MEDP	588.33	14.2	48.4	15.12
2026-01-26	MEDP	602.34	14.2	79.5	15.12
2026-01-27	MEDP	602.23	14.2	65.6	15.12
2026-01-28	MEDP	597.53	14.2	60.9	15.12
2026-01-29	MEDP	593.26	14.2	61.0	15.12
2026-01-30	MEDP	582.21	14.2	55.4	15.12
2026-02-02	MEDP	588.37	14.2	71.3	15.12
2026-02-03	MEDP	568.51	14.8	46.1	15.12
2026-02-04	MEDP	562.07	14.8	58.9	15.12
2026-02-05	MEDP	541.53	14.8	44.3	15.12
2026-02-06	MEDP	541.71	14.8	65.7	15.12
2026-02-09	MEDP	530.92	14.8	53.5	15.12
2026-02-10	MEDP	446.33	14.8	-19.1	15.12
2026-02-11	MEDP	423.70	14.8	35.4	15.12
2026-02-12	MEDP	416.23	4.6	26.8	16.74
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-01-14	MEDP	-9.18	-8.80	6.29
2026-01-15	MEDP	-9.18	-8.80	6.29
2026-01-16	MEDP	-9.18	-8.80	6.29
2026-01-20	MEDP	-9.18	-8.82	6.29
2026-01-21	MEDP	-9.18	-8.82	6.29
2026-01-22	MEDP	-9.18	-8.82	6.29
2026-01-23	MEDP	-9.18	-8.82	6.29
2026-01-26	MEDP	-9.18	-8.81	6.29
2026-01-27	MEDP	-9.18	-8.81	6.29
2026-01-28	MEDP	-9.18	-8.81	6.05
2026-01-29	MEDP	-8.36	-8.81	6.05
2026-01-30	MEDP	-7.45	-8.81	6.05
2026-02-02	MEDP	-7.45	-8.30	6.05
2026-02-03	MEDP	-7.45	-8.30	6.05
2026-02-04	MEDP	-7.45	-8.30	6.05
2026-02-05	MEDP	-7.45	-8.30	6.05
2026-02-06	MEDP	-7.45	-8.30	6.05
2026-02-09	MEDP	-7.45	-7.63	6.05
2026-02-10	MEDP	-7.45	-7.63	6.05
2026-02-11	MEDP	-7.45	-7.63	5.92
2026-02-12	MEDP	-7.45	-7.63	5.87
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

4.67

Avg. EPS Est. Current Quarter

3.84

Avg. EPS Est. Next Quarter

3.96

Insider Transactions

-7.45

Institutional Transactions

-7.63

Beta

1.43

Average Sales Estimate Current Quarter

682

Average Sales Estimate Next Quarter

693

Fair Value

554.94

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

33.8

Max Drawdown 5-Year %

-42.9

Target Price

505.18

P/E

27.21

Forward P/E

21.89

PEG

1.79

P/S

4.67

P/B

25.65

P/Free Cash Flow

17.32

EPS

15.29

Average EPS Est. Cur. Y

16.74

EPS Next Y. (Est.)

18.55

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

17.83

Relative Volume

2.46

Return on Equity vs Sector %

70.4

Return on Equity vs Industry %

87.4

EPS 1 7Days Diff

0.2

EPS 1 30Days Diff

0.23

EBIT Estimation

26.8

Medpace Holdings, Inc.

Sector: Healthcare

Industry: Diagnostics & Research

Employees: 6200

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.

stock quote shares MEDP – Medpace Holdings, Inc. Stock Price stock today

news today MEDP – Medpace Holdings, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch MEDP – Medpace Holdings, Inc. yahoo finance google finance

stock history MEDP – Medpace Holdings, Inc. invest stock market

stock prices MEDP premarket after hours

ticker MEDP fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: MEDP

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y